lobbying_activities: 3340147

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3340147	848e9fc9-57cc-4a92-b58f-d878d406c25b	Q1	BURRELL INTERNATIONAL GROUP LLC	401103483	TONIX PHARMACEUTICALS HOLDING CORP.	2025	first_quarter	PHA	LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY26 Defense Appropriation for broad-spectrum antivirals, FY26 LHHS for Long COVID and cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2025-04-17T11:45:34-04:00